Peptides Vietnam LogoPeptides Vietnam
Weight Loss Calculator

Retatrutide Weight Loss Calculator

Estimate your weight loss timeline on Retatrutide from your own stats. It uses a Mifflin-St Jeor energy balance plus our own conservative assumption of about 0.5% of body weight lost per week.

That weekly rate is our assumption, not a figure reported by the NEJM Phase 2 trial, which is cited here as context. Individual results vary.

Retatrutide is investigational and not yet approved anywhere; see when will retatrutide be available for where FDA approval stands. To mix any vial and read the syringe units, use the general peptide calculator. To see retatrutide beside every other peptide and whether each one has a published human dose, open the peptide dosage chart.

Quick answer: retatrutide dose to units

The 2023 New England Journal of Medicine phase 2 obesity study gave retatrutide once a week in six groups, aiming at four target amounts. All but one of the groups above 1 mg started lower and stepped up:

1, 4, 8 and 12 mg a week as targets; 4 mg and 8 mg each had one arm starting at 2 mg and one at 4 mg, and 12 mg started at 2 mg.

Disclaimer: trial figures, not a dose to copy.

Reading a trial amount as syringe units depends on how you mixed the vial. The grid takes a 10 mg vial and shows each weekly amount at 1, 2 and 3 mL of water.

Weekly target10 mg in 1 mL10 mg in 2 mL10 mg in 3 mL
1 mg10 units20 units30 units
4 mg40 units80 units120 units (more than 1 mL)
8 mg80 units160 units (more than 1 mL)240 units (more than 1 mL)
12 mgmore than one 10 mg vialmore than one 10 mg vialmore than one 10 mg vial

These units are for a U-100 syringe and round to one decimal. A higher weekly amount needs a bigger vial or more than one draw. To try other vial and water numbers, open the retatrutide reconstitution calculator.

Disclaimer: this converts amounts, it does not pick one.

Retatrutide dosage calculator rows for 10, 20 and 30 mg vials

With 2 mL of water, 4 mg is 80 units in a 10 mg vial, 40 units in a 20 mg vial and 26.7 units in a 30 mg vial. The rows use the same four weekly targets from the 2023 NEJM phase 2 trial:

1, 4, 8 and 12 mg once a week.

Weekly target10 mg + 2 mL (5 mg/mL)20 mg + 2 mL (10 mg/mL)30 mg + 2 mL (15 mg/mL)
1 mg0.2 mL, 20 units0.1 mL, 10 units0.07 mL, 6.7 units
4 mg0.8 mL, 80 units0.4 mL, 40 units0.27 mL, 26.7 units
8 mg1.6 mL, 160 units (more than 1 mL)0.8 mL, 80 units0.53 mL, 53.3 units
12 mgmore than the 10 mg in the vial1.2 mL, 120 units (more than 1 mL)0.8 mL, 80 units

Target over strength gives the volume; move the decimal two places for the unit count. Example: 8 mg / 15 mg per mL = 0.53 mL, or 53.3 units.

Disclaimer: trial targets turned into volumes for reading a syringe, not a dose for any person.

Sources: Retatrutide phase 2 obesity trial, New England Journal of Medicine 2023 (PMID 37366315)

Units:
35 years
18 years80 years
90 kg
50 kg200 kg
75 kg
40 kg195 kg
175 cm
140 cm220 cm
2000 kcal
1000 kcal4000 kcal

How many calories should I eat on retatrutide? See our calorie guide for retatrutide.

Dosing calculator: vial, BAC water, and syringe units

The projection above is about outcomes. This part is about measurement. Enter the vial size, how much bacteriostatic water you plan to add, and the dose from your own protocol, and it returns the concentration, the volume to draw, and where that lands on a U-100 insulin syringe. It does the arithmetic only. It does not tell you what dose to take.

10 mg
1 mg30 mg
2 mL
0.5 mL5 mL
2 mg
0.1 mg15 mg
mg

Result

Concentration

5 mg/mL

Volume per dose

0.4 mL

Insulin syringe units

40 units

U-100, where 1 unit is 0.01 mL

Doses per vial

5

Assuming exact reconstitution

The total peptide in the vial never changes with the water you add. Only the concentration changes, and with it the volume you draw. Dose decisions belong with your protocol source and a qualified clinician.

How the calculator works

This tool turns your own numbers into a projection. It first estimates your daily energy burn with the Mifflin-St Jeor equation,2 then models week-by-week weight change from our own conservative assumption of about 0.5 percent of body weight per week plus whatever calorie deficit you set. That weekly rate is our assumption, not a figure the published Phase 2 Retatrutide trial reported; the trial is cited on this page as context. The outputs are BMI, total daily energy expenditure, the weight you would need to lose to reach your goal, and projected body weight at 12, 24, and 48 weeks. None of this is a prescription. It is a planning estimate, and individual results vary. The daily calorie target is set by you and your clinician, because the retatrutide trials never set one; how many calories should I eat on retatrutide covers what those trials told people to eat instead.

Retatrutide arrives as a freeze-dried powder, so it has to be reconstituted before any dose can be measured.5 Reconstitution means dissolving the powder in bacteriostatic water to reach a known concentration, which is what makes an accurate draw possible. Adding more water lowers the concentration and raises the volume you draw; adding less does the opposite. The total peptide in the vial stays the same either way. If you want to see that concentration math for a specific vial, the peptide reconstitution calculator handles it, the retatrutide-specific version does the same for this compound, and the beginner injection guide walks through the mixing and measuring steps in plain terms.

One common question before mixing is which liquid to use. Bacteriostatic water contains a preservative that keeps a reconstituted vial stable for weeks, while plain sterile water does not, and the difference matters for shelf life.67 The BAC water vs sterile water FAQ covers that distinction. For the background on what Retatrutide is, how its triple-receptor mechanism differs from single and dual agonists, and what the research reports, read the full Retatrutide guide.

How much weight can you lose on retatrutide in a month?

No study reports a monthly figure, but the trial average works out to roughly 1.3% to 3.2% of body weight a month over the first 24 weeks, depending on the dose group. The 2023 NEJM phase 2 report gave these mean changes from starting weight:

GroupWeek 24Week 48Week 24 spread per month
1 mg-7.2%-8.7%about 1.3%
4 mg (combined)-12.9%-17.1%about 2.3%
8 mg (combined)-17.3%-22.8%about 3.1%
12 mg-17.5%-24.2%about 3.2%
Placebo-1.6%-2.1%about 0.3%

The last column is our own arithmetic: week 24 is about 5.5 months (24 x 7 / 30.4), so 17.5 / 5.5 = 3.2. These are group averages, and loss was faster early and slower later. The calculator above plans with a slower 0.5% a week, which is about 2.2% a month (0.5 x 4.35).

Disclaimer: trial averages, not a result anyone can expect. Educational only, not medical advice.

Sources: Retatrutide phase 2 obesity trial, New England Journal of Medicine 2023 (PMID 37366315)

What are the side effects of retatrutide in trials?

Stomach and gut effects were the most common in the 2023 NEJM phase 2 trial. The paper reports that:

  • gastrointestinal events rose with dose
  • most were mild to moderate
  • a 2 mg start eased them partly, compared with a 4 mg start
  • heart rate went up with dose, peaked at 24 weeks, then came down

Disclaimer: this lists what one trial recorded. It is not a full safety profile and not medical advice.

Is retatrutide FDA approved?

No. When we checked on 15 November 2026, the FDA drug approvals database returned no retatrutide product. ClinicalTrials.gov lists its phase 3 program, named TRIUMPH, with some studies completed and others still running. That also means there is no approved retatrutide pen.

How does retatrutide work?

It is one molecule that acts on three hormone receptors: GIP, GLP-1 and glucagon. That is why papers call it a triple agonist.

Sources: Retatrutide phase 2 obesity trial, NEJM 2023 (PMID 37366315); openFDA Drugs@FDA search for retatrutide, checked 2026-11-15; ClinicalTrials.gov, retatrutide phase 3 studies

Use, share or cite this calculator

Embed it on your site, copy a citation, or add Peptides Vietnam as a preferred source on Google.

Frequently asked questions

What does this Retatrutide calculator do?

It estimates a weight loss timeline from your own stats. It pairs the Mifflin-St Jeor equation for daily energy burn with our own conservative assumption of about 0.5 percent of body weight lost per week, which is not a figure the published Phase 2 Retatrutide trial reported. That trial is cited on this page as context only. You enter your weight, goal weight, height, age, activity, calorie target, and protein level, and it projects body weight at 12, 24, and 48 weeks, your BMI, your daily energy burn (TDEE), and how those numbers shift when a calorie deficit is added on top. The outputs are projections for education, not medical instructions, and individual results vary.

What does reconstitution mean for a peptide like Retatrutide?

Retatrutide ships as a freeze-dried (lyophilized) powder that has to be dissolved in liquid before it can be measured. Reconstitution is that mixing step: adding bacteriostatic water to the vial turns the powder into a solution at a known concentration, which is what lets a dose be drawn accurately. The amount of water you add changes the concentration and the volume you draw, not the total amount of peptide in the vial. Our peptide reconstitution calculator handles that concentration math.

How accurate are the weight loss projections?

They are estimates, not guarantees. The model pairs the Mifflin-St Jeor equation for energy burn with a deliberately conservative drug-effect assumption of about 0.5 percent of body weight per week, applied on top of whatever calorie deficit your inputs produce. That weekly rate is our own conservative assumption and not a figure the trial reported: the Phase 2 trial reported a 24.2 percent mean weight loss at the highest dose over 48 weeks, under trial conditions that included a supervised lifestyle programme. Your real numbers depend on diet, sleep, training, genetics, and consistency, so treat the timeline as a planning reference rather than a promise.

Does protein intake affect how much muscle I keep?

Rapid weight loss can cost lean mass alongside fat. Research on weight loss generally reports that higher protein intake and resistance training are associated with better preservation of lean mass during a calorie deficit. That is a direction the research supports, not a number, so this calculator gives you a daily protein target scaled to your body weight and does not put a personal muscle retention percentage on the screen.

What is the dose escalation table in the results?

It records what the 12mg group of the published Phase 2 trial actually did. In that trial, groups assigned 4mg or higher started at either 2mg or 4mg once weekly, followed by gradual dose escalation every 4 weeks for up to 12 weeks. The 12mg group was the arm that started at 2mg, so it reached 12mg from week 13. It is shown as trial context only. It is not a prescription or a personal protocol, and decisions about whether a compound is appropriate for you, and at what dose, belong with a qualified clinician who knows your history. Disclaimer: this is general education, not medical advice and not a dosing recommendation.

Does the calculator work for a retatrutide pen?

The units grid is for a vial you mix yourself, not a pen. A pen comes prefilled and you dial a set amount, so there is no water to add and no units to work out. Retatrutide is still in trials and has no approved pen, so any pen math here would be guesswork.

Reconstitution calculators for other compounds

Same arithmetic, preset to each compound's vial size. Every one starts with the dose field empty and refuses to return a syringe reading for a dose larger than the vial.

Sources

  1. 1.PubMed PMID 37366315
  2. 2.PubMed PMID 2305711
  3. 3.New England Journal of Medicine, NEJMoa2301972 full text, Methods section (Internet Archive, 2026-07-16)
  4. 4.ClinicalTrials.gov NCT04881760, the Phase 2 retatrutide record, arm labels and dose-escalation detail
  5. 5.Peptara Labs, product form and reconstitution FAQ
  6. 6.DailyMed / BACTERIOSTATIC WATER (Hospira) Structured Product Label, SPL setid 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7
  7. 7.DailyMed / STERILE WATER FOR INJECTION Structured Product Label, SPL setid 99e99a50-82d5-aff6-e053-2a95a90a8c56
  8. 8.PubMed PMID 28507015
  9. 9.PubMed PMID 26817506